Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ImmunityBio (IBRX) EPS (Weighted Average and Diluted) (2019 - 2025)

Historic EPS (Weighted Average and Diluted) for ImmunityBio (IBRX) over the last 7 years, with Q3 2025 value amounting to -$0.07.

  • ImmunityBio's EPS (Weighted Average and Diluted) rose 5000.0% to -$0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.41, marking a year-over-year increase of 5543.48%. This contributed to the annual value of -$0.59 for FY2024, which is 4864.8% up from last year.
  • Per ImmunityBio's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.07 for Q3 2025, which was up 5000.0% from -$0.1 recorded in Q2 2025.
  • ImmunityBio's EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.07 during Q3 2025, with a 5-year trough of -$0.38 in Q4 2023.
  • For the 5-year period, ImmunityBio's EPS (Weighted Average and Diluted) averaged around -$0.21, with its median value being -$0.22 (2021).
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first plummeted by 4074.07% in 2023, then soared by 7776.63% in 2024.
  • Over the past 5 years, ImmunityBio's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.23 in 2021, then fell by 17.39% to -$0.27 in 2022, then plummeted by 40.74% to -$0.38 in 2023, then soared by 77.77% to -$0.08 in 2024, then rose by 17.15% to -$0.07 in 2025.
  • Its last three reported values are -$0.07 in Q3 2025, -$0.1 for Q2 2025, and -$0.15 during Q1 2025.